Trials / Active Not Recruiting
Active Not RecruitingNCT06174402
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
- Status
- Active Not Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 184 (estimated)
- Sponsor
- Han Ying · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main objectives of the study were to assess the effects of fenofibrate on serum alkaline phosphatase, as a composite endpoint and on safety in participants with primary biliary cholangitis (PBC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fenofibrate | Fenofibrate 200 mg/day |
| DRUG | Placebo | 1 tablet/ day |
| DRUG | UDCA | UDCA 13-15mg/kg/day |
Timeline
- Start date
- 2023-08-21
- Primary completion
- 2026-07-01
- Completion
- 2026-12-31
- First posted
- 2023-12-18
- Last updated
- 2026-01-08
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06174402. Inclusion in this directory is not an endorsement.